Genomic Test Menu

Informed Consent Requirements

Informed Consent Form

Insurance Prior Authorization Information

ACMG/NSGC Practice Guidelines: Cancer Predisposition Assessment
NCCN Guidelines, Genetic/Familial High-Risk Assessment: Colorectal
NCCN Guidelines, Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 

Germline/Hereditary Testing

Inherited Diseases  (Non-Cancer) Testing

Cystic Fibrosis

Thrombophilia Risk Panel

Fragile X Syndrome

Hereditary Hemochromatosis

Bile Acid Defects Gene Sequencing Panel

Cystic Diseases of Liver/Kidney Gene Sequencing Panel

Familial Amyloidosis (hATTR)(TTR) Gene Sequencing Panel

Gilbert/Crigler-Najjar Syndrome (UGT1A1)

Jaundice Gene Sequencing Panel

Liver Disease/Cholestasis Gene Sequencing Panel

Wilson Disease (ATP7B) Gene Sequencing Panel

Familia Mediterranean Fever (MEFV) Gene Sequencing Panel

CADASIL (NOTCH3) Gene Sequencing

Prolactinoma Gene Sequencing Panel

Short Stature (SHOX) Gene Sequencing

Apolipoprotein (APOE) Genotyping (e2,e3,e4)

Pharmacogenomics

PGx - Cytochrome P450 2C19 (CYP2C19)

PGx - P450 2C9 (CYP2C9)

PGx - Cytochrome CYPSA4

PGx - DPYD Genotyping

PGX-UGT1A1

Hereditary Breast and Ovarian Cancer Predisposition Panels

BRCA1/2 Sequencing & Full Deletions/ Duplications

Hereditary Breast & Ovarian Cancer Panel (20 genes)

Hereditary Breast Cancer Risk Panel (13 genes)

HFCI Hereditary Cancer Risk- Breast & Related Cancer Workup (up to 55 genes)

Hereditary Multi Cancer Risk Assessment Panel (55 genes)

Custom Hereditary Cancer Risk Panel

Expanded Analysis of Previous Hereditary Risk Testing

Other Hereditary Cancer Predisposition Panels

Hereditary Colorectal Cancer Risk Panel (21 genes)

Hereditary Endometrial Cancer Risk Panel (17 genes)

Hereditary Melanoma Risk Panel (10 genes)

Hereditary Multi Cancer Risk Assessment Panel (55 genes)

Hereditary Neuroendocrine Tumor Disorders Risk Panel (15 genes)

Hereditary Prostate Caner Panel (16)

Hereditary Renal / Urinary Tract Cancer Panel (27 genes)

Custom Hereditary Cancer Risk Panel

Expanded Analysis of Previous Hereditary Risk Testing

 

Hematologic and Hematolymphoid Molecular Testing

Hematologic and Hematolymphoid Molecular Panel Testing

DNA Based:

B Cell Gene Rearrangement

T Cell Beta Gene Rearrangement

T Cell Gamma Gene Rearrangement

RNA: RT-PCR

p190-ALL, BCR/ABL t(9:22)

p210-CML, BCR/ABL t(9:22)

PML/RARA t(15:17)

CBFB/MYH11 inv(16)

NGS sequencing:

Myeloproliferative Panel

Rapid AML Sequencing Panel

CLL/SLL Sequencing Panel

ALL Sequencing Panel

Myeloid PLUS Sequencing Panel

Lymphoid Neoplasm Sequencing Panel

RNA Fusion Panel

Hematolymphoid Neoplasm or Disorders Sequencing Custom Panel (1-4 genes)

Hematolymphoid Neoplasm or Disorders Sequencing Custom Panel (5-50 genes)

Commonly Ordered Individual Hematolymphoid Next Generation Gene

(If selecting >1 gene, see panel above)

NGS sequencing:

CALR Mutation 

Heme - IDH1

Heme - IDH2

JAK-2

Heme - MPL

MHeme-MYD88

NPM1 Mutation

Rapid FLT3 Mutation Assessment

 

Solid Tumor Molecular Testing

Solid-Tumor Lung Testing

PD-L1 Expression by ImmunoHistoChemistry (IHC)

EGFR TKI Sensitivity and Resistance Mutation

MET Gene Mutation

HFCI Lung Cancer Molecular Workup 

Expanded HFCI Panel

Solid-Tumor Colorectal and Lynch Syndrome Testing

Colorectal Solid Tumor Gene Sequencing Panel

KRAS Mutation Detection

NRAS Mutation Detection

BRAF Mutation Detection

Microsatellite Instability (MSI) Testing, IHC, MLH1 - Lynch Syndrome

Immunohistochemistry for MLH1, MSH2, MSH6 and PMS2 protein expression

MLH1 Promoter Methylation Detection

Germline -Lynch Syndrome Panel (5 genes)

Solid-Tumor Neuro-Oncology Testing

Glioma Solid Tumor Sequencing Panel

EGFRvIII mutation in Gliomas

IDH1 Solid Tumor Mutation

IDH2 Solid Tumor Mutation

MGMT Methylation in Gliomas

BRAF Solid Tumor Gene Mutation

Microarray, Parrafin Embedded Tumor (available in Cytogenetics)

Solid-Tumor Gastrointestinal Testing

Gastrointestinal Stromal Solid Tumor Gene Sequencing Panel

PDGFRA Solid Tumor Gene Mutation

KIT Solid Tumor Gene Mutation

Solid-Tumor Melanoma Testing

Melanoma Solid Tumor Gene Sequencing Panel

Microarray, Parrafin Embedded Tumor (available in Cytogenetics)

Solid-Tumor Fusion Testing

Sarcoma Gene Fusion Panel (26 genes)

Comprehensive Solid Tumor Gene Fusion Panel (>50)

Solid-Tumor Breast Testing

Breast Cancer Solid Tumor Gene Sequencing Panel

Immunohistochemical (IHC) HER2, ER/PR, p16

Solid-Tumor Comprehensive and Custom Panels

Solid Tumor Individual Gene Sequencing (1-4 Genes)

Solid Tumor Gene Sequencing Custom Panel (5-50 Genes)

Comprehensive Solid Tumor Cancer Panel (170 genes)

 

Other Misc. Testing

Gestational Disease Profile

Tissue/Patient Identification by DNA Analysis (Non-paternity)

Microsatellite Instability (MSI) + IHC

MLH1 Methylation

Epstein-Barr Virus (EBV) detection by in-situ hybridization